维普期刊资源整合服务平台（V6.5）

113篇 您的检索式：作者名="Natanson"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis显示文摘	Minneci P Deans K Natanson C	2003	Eur J Clin Microbiol Infect2003，22，1：	1
2	Novel therapies for sepsis: a review显示文摘	Dean kj Haley M Natanson C	2005	J Trauma2005，58，：	1
3	Serial cadiovascular variables in surviviors and nonsurvivors of human septic shock:heart rate as an early predictor of prognosis显示文摘	Parker SM Sheilhamer JH Natanson C	1987	Crit Care Med1987，19，10：	1
4	Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis显示文摘	MARGARET M. PARKER JAMES H. SHELHAMER CHARLES NATANSON DAVID W. ALLING JOSEPH E. PARRILLO	1987	Critical Care Medicine1987，，10：	1
5	Increasing the efficacy of anti-inflammatoryagents used in the treatment of sepsis显示文摘	Minneci P Deans K Natanson C	2003	Eur J Clin Microbiol Infect Dis2003，22，1：	1
6	Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis显示文摘	Natanson C Hoffman WD Suffreclini AF	1994	Ann Intern Med1994，120，9：	1
7	Septic shock in humans:advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy 显示文摘	PARRILLO J E PARKER M M NATANSON C	1990	Ann Intern Med1990，113，：	1
8	Early goal-directed therapy reduced mortality and muhiorgan dysfunction in severe sepsis or septic shock 显示文摘	Natanson C Danner RL	2002	ACP J Club2002，136，3：	1
9	Septic shock in humans advances in the understanding of prognosis cardiovascular dysfunction and therapy显示文摘	Parrillo JE Parker MM Natanson C	1990	Ann Intem Med1990，113，3：	1
10	Separating practice guidelines from pharmaceutical marketing 显示文摘	Eichacker PQ Natanson C Danner RL	2007	Crit Care Med2007，35，12：	1
11	Anti-inflammatory therapies in sepsis and septic shock显示文摘	Freeman B Natanson C	2000	Expert Opin Investig Drugs2000，9，7：	1
12	Increasing the Efficacy of Anti-Inflammatory Agents Used in the Treatment of Sepsis显示文摘	P. Minneci K. Deans C. Natanson P. Q. Eichacker	2003	European Journal of Clinical Microbiology & Infectious Diseases2003，，1：	1
13	Anti-inflammatory therapies in insepsis and septic shock显示文摘	Freeman BD Natanson C	2000	Expert Opin Investig Drugs2000，9，7：	1
14	Endotoxin and tumor necrosis factor chanllenges in dogs simulate the cardiovascular profile of human septic shock显示文摘	Natanson C Eichenholz PW Danner RL	1989	Exp Med1989，169，：	1
15	Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis 显示文摘	Hoffman WD Suffredini AF	1994	Ann Intern Med1994，120，9：	1
16	Anti-inflammato ry therapies to treat sepsis and septic shoek areas sessment显示文摘	Zeni F Freeman B Natanson C	1997	Crit Care Med1997，25，7：	1
17	Vascular endothelial growth factor,epidermal growth factor and fibroblast growth factor 4 and 10 stimulate trophoblast plasminogen activator system and metalloproteinase-9显示文摘	Anteby EY Greenfield C Natanson Yaron S	2004	Mol Hum Reprod2004，10，4：	1
18	Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment 显示文摘	Zeni F Freeman B Natanson C	1997	Crit Care Med1997，25，7：	1
19	Septic shock in humans:advances in the understanding of prognosis,cardiovascular dysfunction,and therapy显示文摘	Parrillo JE Parker MM Natanson C	1990	Ann Intern Med1990，113，3：	1
20	Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment 显示文摘	Zeni F Freeman B Natanson C	1997	Crit Care Med1997，25，7：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示